Home > Insider Trading > Filing (0001127602-20-030120)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Bausch Health Companies Inc.	BHC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1674278	D. William Humphries	400 Somerset Corporate Boulevard Bridgewater NJ 08807	President, Ortho-Dermatologics	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares, No Par Value	Acquisiton	2020-11-23	1,483	$14.38	236,518	No	4	M	Direct
Common Shares, No Par Value	Acquisiton	2020-11-24	21,658	$14.38	258,176	No	4	M	Direct
Common Shares, No Par Value	Disposition	2020-11-23	1,483	$19.63	235,035	No	4	S	Direct
Common Shares, No Par Value	Disposition	2020-11-24	21,658	$19.63	235,035	No	4	S	Direct
Common Shares, No Par Value	Acquisiton	2020-11-27	13,663	$14.38	248,698	No	4	M	Direct
Common Shares, No Par Value	Disposition	2020-11-27	13,663	$19.63	235,035	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares, No Par Value	Non-qualified Stock Options (right To Purchase)	Disposition	2020-11-23	1,483	$0.00	1,483	$14.38
Common Shares, No Par Value	Non-qualified Stock Options (right To Purchase)	Disposition	2020-11-24	21,658	$0.00	21,658	$14.38
Common Shares, No Par Value	Non-qualified Stock Options (right To Purchase)	Disposition	2020-11-27	13,663	$0.00	13,663	$14.38

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
149,376	2027-03-01	No	4	M	Direct
127,718	2027-03-01	No	4	M	Direct
114,055	2027-03-01	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.64 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.66 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.635 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote.
The options vest in equal installments on each of the first three anniversaries of the date of grant.